Urayasu, Japan

Sakae Torisawa

This inventor holds 1 USPTO granted patent. Top assignee: Tti Ellebeau, Inc.. Active years: 2008.


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sakae Torisawa: Innovator in Iontophoresis Technology

Introduction

Sakae Torisawa is a notable inventor based in Urayasu, Japan. He has made significant contributions to the field of medical technology, particularly through his innovative work on iontophoresis devices. His inventions aim to improve the administration of ionic drugs, enhancing treatment efficiency and patient comfort.

Latest Patents

Torisawa holds a patent for an iontophoresis device designed for the effective delivery of ionic drugs. This device features an iontophoresis electrode section and a ground electrode section, both connected to a power source. The unique design incorporates membrane bodies and ion exchange membranes that differ in ion selectivity. This allows for stable administration of ionic drugs over extended periods, achieving high transport efficiency.

Career Highlights

Throughout his career, Sakae Torisawa has been associated with Tti Ellebeau, Inc., where he has focused on developing advanced medical devices. His work has garnered attention for its potential to revolutionize drug delivery methods, making treatments more effective and less invasive.

Collaborations

Torisawa has collaborated with notable colleagues, including Akihiko Matsumura and Kiyoshi Kanamura. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Sakae Torisawa's contributions to iontophoresis technology exemplify the impact of innovative thinking in the medical field. His work continues to pave the way for more effective drug delivery systems, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…